New Releases from NCBI BookshelfEfgartigimod for treating antibody-positive generalised myasthenia gravis.Efgartigimod for treating antibody-positive generalised myasthenia gravis.
Post Content
Type 2 diabetes (T2D) is a potential risk factor for poor outcomes associated with COVID-19, as are associated conditions including
Fluid removal is a key component of dialysis treatment but, if excessive, can result in a faster decline in residual
In patients who require mechanical ventilation for acute hypoxaemic respiratory failure, further reduction in tidal volumes, compared with conventional low
Approximately 1 in 3 American adults has hypertension. Lowering blood pressure (BP) to recommended levels has been shown to reduce
Exercise-based cardiac rehabilitation (CR) programs reduce mortality and improve quality of life in patients with coronary heart disease (CHD). However,